Image

Global Injectable Drug Delivery Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Injectable Drug Delivery Market, By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Formulation Packaging (Ampoules, Vials, Cartridges, Bottles), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Cancer, Others),  Usage Pattern (Curative Care, Immunization, Other), Site Of Administration (Skin, Circulatory/Musculoskeletal System, Organs, Central Nervous System), Distribution Channel (Hospital, Retail Pharmacy Stores), End User (Hospitals and Clinics, Home Care Settings, Others) – Industry Trends and Forecast to 2029

Injectable Drug Delivery Market

Global Injectable Drug Delivery Market Analysis and Size

The market for injectable drug delivery is estimated to increase rapidly over the forecast period. Sedentary lifestyles have spread over the world as a result of rapid technological adoption. Obesity rates are rising as a result of this shift in lifestyle, which is leading to a slew of chronic ailments including diabetes and cardiovascular disease. With the development of chronic diseases, healthcare systems' desire to focus more on advanced drug delivery technologies has skyrocketed. Hence, this led to the introduction of injectable drug delivery devices in the market.

  • Data Bridge Market Research analyses that the injectable drug delivery market was valued at USD 17.13 billion in 2021 and is expected to reach USD 46.84 billion by 2029, registering a CAGR of 13.40% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Injectable Drug Delivery Market Definition

Formulations, techniques, technologies, and systems for conveying a pharmaceutical ingredient in the body are collectively referred to as drug delivery. Needle-free injectors, traditional syringes, auto injectors, and pen injectors are among the injectable drug delivery systems.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Formulation Packaging (Ampoules, Vials, Cartridges, Bottles), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Cancer, Others),  Usage Pattern (Curative Care, Immunization, Other), Site Of Administration (Skin, Circulatory/Musculoskeletal System, Organs, Central Nervous System), Distribution Channel (Hospital, Retail Pharmacy Stores), End User (Hospitals and Clinics, Home Care Settings, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Abbott (U.S.), B.D. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Baxter (U.S.), Gerresheimer AG (Germany), AstraZeneca (U.K.), Terumo Medical Corporation (Japan), Teva Pharmaceutical Industries Ltd.(Jerusalem), Eli Lilly and Company (U.S.), Schott AG (Germany), Sanofi (France), Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), West Pharmaceutical Services, Inc. (U.S.), SHL Medical AG (Switzerland), Insulet Corporation (U.S.), E3D Elcam Drug Delivery Devices (Israel), Ypsomed AG (Switzerland), AbbVie Inc. (U.S.), Novo Nordisk A/S (Denmark)

Injectable Drug Delivery Market Dynamics

Drivers

  • Increasing incidences of chronic diseases will drive the market's growth rate

Due to the effective and focused drug release as well as low side-effects on the body, the global drug delivery market is primarily driven by rising prevalence of chronic diseases such as cancer around the world.

  • Rising number of geriatric population will propel the growth rate of market during the forecast period

The rising geriatric population is driving the global injectable drug delivery market. The geriatric population necessitates a bigger supply of generic medications and dosages. Growing old comes with a slew of ailments, which has resulted in a spike in the medicine delivery sector.

Furthermore, the incrementing global biologics and biosimilar market will be a major factor influencing the growth of the injectable drug delivery market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the injectable drug delivery market. Also, the rise in the changing lifestyle and increasing expenditure on healthcare infrastructure are the major market drivers that will further escalate the growth of injectable drug delivery market. Other significant factors that will cushion the injectable drug delivery market's growth rate are increasing promotion of new products and new innovations.

Opportunities

  • Growing number of R&D activities will boost many market opportunities during the forecast period

Moreover, the rising number of research and development activities will provide beneficial opportunities for growth in the injectable drug delivery market.Moreover, advanced prodrug implants, chip-based drug delivery, and technological advancement will provide beneficial opportunities for the market growth of the injectable drug delivery during the forecast period.

Restraints/Challenges Global Injectable Drug Delivery Market

  • Increasing contraceptive injectable preference for other mode of delivery will hamper the market's growth rate

As a result of the increased surface area available for absorption, injectable medication delivery achieves rapid systemic absorption levels. On the other hand, injectables can cause needle stick injuries and infections, as well as needle phobia, anxiety, and discomfort. To some extent, all of these issues limit the market for injectables.

  • Frequent product recalls pose a major challenge for the growth of market during the forecast period

In recent years, there have been multiple product recalls in the injectable medicine delivery technology sector. Recalls can be voluntary or come from regulatory action. Injectables have also been recalled due to contamination from inorganic materials such as glass, silicone, stainless steel, and improper vial filling.

On the other hand, injuries and infections caused by needles will challenge the injectable drug delivery market. Additionally, growing use of alternative delivery methods and lack of awareness will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.

This injectable drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the injectable drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Injectable Drug Delivery Market

Coronavirus is a highly contagious disease that mostly affects people's respiratory systems. The COVID-19 has afflicted people all around the world. Except for the pharmaceutical business, it had a negative impact on the running of all industries. More ventilators, testing kits, pharmaceuticals, vaccines, and oxygen cylinders are needed now than before the global pandemic. In recent years, the demand for injectable devices and other healthcare items has increased, resulting in a boom in the injectable drug delivery devices business. Every country's government is devoting a significant portion of its financial resources to acquiring and manufacturing more medicinal products and medical equipment. Vaccinations are being given to people all around the world. As a result, the market for injectable drug delivery systems is expanding.

Recent Development

  • In January 2022, West had announced Landmark collaboration with Corning Incorporated in pharmaceutical injectable drug delivery. Corning's Valor Glass technology will be expanded to enable enhanced injectable drug packaging and delivery systems for the pharmaceutical industry as part of the new collaboration, to improve patient safety and broaden access to life-saving therapies.

Global Injectable Drug Delivery Market Scope

The injectable drug delivery market is segmented on the basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Injectable Drug Delivery Devices
  • Injectable Drug Delivery Formulation

On the basis of type, the injectable drug delivery market is segmented into injectable drug delivery devices and injectable drug delivery formulation. Injectable drug delivery devices have further been segmented into conventional injection devices and self-injection devices. Self-injection devices have further been sub-segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors and others. Injectable drug delivery formulation has further been segmented into conventional drug delivery formulation, novel drug delivery formulation and long-acting injection formulations. Novel drug delivery formulation has further been sub-segmented into colloidal dispersions and microparticles. Colloidal dispersions are further divided into niosomes, liposomes, polymeric/mixed micelles and nanoparticles. Micro particles are further divided into microspheres and microcapsules.

Formulation Packaging

  • Ampoules
  • Vials
  • Cartridges
  • Bottles

On the basis of formulation packaging, the injectable drug delivery market is segmented into ampoules, vials, cartridges and bottles.

Therapeutic Application

  • Autoimmune Diseases
  • Hormonal Disorders
  • Orphan Diseases
  • Cancer
  • Others

Based on therapeutic application, the injectable drug delivery market is segmented into autoimmune diseases, hormonal disorders, orphan diseases, cancer and others.

Usage Pattern

  • Curative Care
  • Immunization
  • Other

On the basis of usage pattern, the injectable drug delivery market is segmented into curative care, immunization and others.

Site of Administration

  • Skin
  • Circulatory/Musculoskeletal System
  • Organs
  • Central Nervous System

Based on site of administration, the injectable drug delivery market is segmented into skin, circulatory/musculoskeletal system, organs and central nervous system.

Distribution Channel

  • Hospital
  • Retail Pharmacy Stores

On the basis of distribution channel, the injectable drug delivery market is segmented into hospital and retail pharmacy stores.

End User

  • Hospitals and Clinics
  • Home Care Settings
  • Others

The end user segment of injectable drug delivery market is segmented into hospitals and clinics, home care settings and others.

 Injectable Drug Delivery Market Regional Analysis/Insights

The injectable drug delivery market is analysed and market size insights and trends are provided by country, type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel and end user as referenced above.

The countries covered in the injectable drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the injectable drug delivery market because of the increasing adoption of advanced injectable drug delivery and a large patient pool. Additionally, rising expenditure for healthcare infrastructure will flourish the market's growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to rising awareness and increasing number of patient population in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The injectable drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for injectable drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the injectable drug delivery market. The data is available for historic period 2010-2020.

Competitive Landscape and Injectable Drug Delivery Market Share Analysis

The Injectable drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to injectable drug delivery market.

Some of the major players operating in the injectable drug delivery market Abbott (U.S.), B.D. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Baxter (U.S.), Gerresheimer AG (Germany), AstraZeneca (U.K.), Terumo Medical Corporation (Japan), Teva Pharmaceutical Industries Ltd.(Jerusalem), Eli Lilly and Company (U.S.), Schott AG (Germany), Sanofi (France), Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), West Pharmaceutical Services, Inc. (U.S.), SHL Medical AG (Switzerland), Insulet Corporation (U.S.), E3D Elcam Drug Delivery Devices (Israel), Ypsomed AG (Switzerland), AbbVie Inc. (U.S.), and Novo Nordisk A/S (Denmark), among others.

Research Methodology : Global Injectable Drug Delivery Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-injectable-drug-delivery-market

Customization Available : Global Injectable Drug Delivery Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Injectable Drug Delivery Market will be projected USD 46.84 billion during the forecast period of 2022 to 2029.
The Injectable Drug Delivery Market is to Grow at a CAGR of 13.40% During the Forecast Period of 2022 to 2029.
The Expansion of the Global Injectable Drug Delivery Market will be fueled by the incrementing global biologics and biosimilar market and rising number of geriatric population. Additionally, increasing promotion of new products and increasing incidences of chronic diseases will enhance the growth rate of Global Injectable Drug Delivery Market.
Abbott (U.S.), B.D. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Baxter (U.S.), Gerresheimer AG (Germany), AstraZeneca (U.K.), Terumo Medical Corporation (Japan), Teva Pharmaceutical Industries Ltd.(Jerusalem), Eli Lilly and Company (U.S.), Schott AG (Germany), Sanofi (France), Johnson & Johnson Private Limited (U.S.) are the major companies operating in Injectable Drug Delivery Market.
The Countries Covered in the Injectable Drug Delivery Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.